|
NAPG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.63729999999885E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.38009999997679E-06 |
| Normal-vs-Stage2 |
5.76660000000118E-05 |
| Normal-vs-Stage3 |
1.65722999999618E-05 |
| Normal-vs-Stage4 |
3.141900E-02 |
| Stage1-vs-Stage2 |
7.713200E-01 |
| Stage1-vs-Stage3 |
2.072800E-01 |
| Stage1-vs-Stage4 |
6.222800E-01 |
| Stage2-vs-Stage3 |
4.738200E-01 |
| Stage2-vs-Stage4 |
8.372000E-01 |
| Stage3-vs-Stage4 |
8.043600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52545999999587E-05 |
| Normal-vs-AfricanAmerican |
2.35199999999436E-05 |
| Normal-vs-Asian |
5.861400E-03 |
| Caucasian-vs-AfricanAmerican |
8.531800E-01 |
| Caucasian-vs-Asian |
7.106200E-01 |
| AfricanAmerican-vs-Asian |
6.330600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.53249999995864E-06 |
| Normal-vs-Female |
2.422400E-04 |
| Male-vs-Female |
3.816400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.960360E-04 |
| Normal-vs-Extreme_Weight |
2.7438999999907E-06 |
| Normal-vs-Obese |
7.61130000026533E-07 |
| Normal-vs-Extreme_Obese |
1.288200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.608800E-01 |
| Normal_Weight-vs-Obese |
5.093200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.712200E-01 |
| Extreme_Weight-vs-Obese |
9.327600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.160000E-01 |
| Obese-vs-Extreme_Obese |
5.592400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.205900E-04 |
| Normal-vs-Age(41-60Yrs) |
5.63080000000049E-05 |
| Normal-vs-Age(61-80Yrs) |
1.83633999999433E-05 |
| Normal-vs-Age(81-100Yrs) |
6.17130000000188E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.072400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.940200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.573000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.955000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.891210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.190600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.06629999996333E-06 |
| Normal-VS-Type2 PRCC |
4.66809999988271E-07 |
| Normal-VS-KIRP CIMP |
6.783400E-03 |
| Normal-VS-Unclassified PRCC |
3.448800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.669010E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.285200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.362000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.192000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.468200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.527600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.58440002521132E-09 |
| Normal-vs-N1 |
4.171800E-04 |
| Normal-vs-N2 |
1.218120E-03 |
| N0-vs-N1 |
3.523800E-01 |
| N0-vs-N2 |
3.297200E-01 |
| N1-vs-N2 |
2.876400E-01 |
|
|
